The lowering of the price target from $12 to $10 by Barclays suggests a less optimistic outlook on Sunnova's stock performance, which could lead to a short-term negative impact on the stock price. However, the Overweight rating indicates that the analyst still sees potential upside, mitigating the negative impact.